Search

everythinglearnresearchcommunity

for

Search:↓

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Lower testosterone levels may increase heart failure risk in older men.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

Both treatments reduced androgen levels and hair growth in women with hirsutism.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

Taking oral testosterone with or without dutasteride increases testosterone levels and could be an effective treatment for low testosterone.

The contraceptive reduced hair growth and altered hormone levels in hirsute women.

The treatment significantly reduced hair growth and male hormone levels in hirsute women.

Men with liver cancer have higher levels of a specific testosterone byproduct in their liver and blood, despite overall lower male hormone levels.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

The new oral testosterone pill normalized testosterone levels and lowered SHBG in men with low testosterone.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

High triglyceride levels are a key factor affecting testosterone levels in women with PCOS.

Chinese women with PCOS have higher androgen levels, which change with age and weight.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

FAI is a reliable marker for identifying and monitoring hyperandrogenism in obese adolescent females with PCOS.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

Early balding in men might be a male hormonal equivalent of polycystic ovaries syndrome in women.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

Certain hormones can reduce skin oil and hair growth, potentially helping treat acne and excessive hair in women.

Probiotic supplements may help reduce inflammation and oxidative stress in women with PCOS.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Curcumin improved some metabolic factors in women with PCOS but did not affect cholesterol, insulin, or testosterone levels.

Perforin and granzyme-B may influence hormone levels in women with PCOS.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

Women with excessive body hair often have higher male hormones and related health issues.